Cargando…

DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer

Expression of oestrogen receptor (ESR1) determines whether a breast cancer patient receives endocrine therapy, but does not guarantee patient response. The molecular factors that define endocrine response in ESR1-positive breast cancer patients remain poorly understood. Here we characterize the DNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stone, Andrew, Zotenko, Elena, Locke, Warwick J., Korbie, Darren, Millar, Ewan K. A., Pidsley, Ruth, Stirzaker, Clare, Graham, Peter, Trau, Matt, Musgrove, Elizabeth A., Nicholson, Robert I., Gee, Julia M. W., Clark, Susan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510968/ https://www.ncbi.nlm.nih.gov/pubmed/26169690 http://dx.doi.org/10.1038/ncomms8758

Ejemplares similares

Multiplex bisulfite PCR resequencing of clinical FFPE DNA
por: Korbie, Darren, et al.
Publicado: (2015)

Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels
por: Lam, Dilys, et al.
Publicado: (2020)

Next-Generation Molecular Discovery: From Bottom-Up In Vivo and In Vitro Approaches to In Silico Top-Down Approaches for Therapeutics Neogenesis
por: Kenny, Sophie E., et al.
Publicado: (2022)

Endocrine therapy: defining the path of least resistance
por: Stone, Andrew, et al.
Publicado: (2014)

Advances in Prognostic Methylation Biomarkers for Prostate Cancer
por: Lam, Dilys, et al.
Publicado: (2020)

Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis
por: Locke, Warwick J, et al.
Publicado: (2015)

Live or let die: oestrogen regulation of survival signalling in endocrine response
por: Butt, Alison J, et al.
Publicado: (2007)

Regulation of Canonical Oncogenic Signaling Pathways in Cancer via DNA Methylation
por: Lu, Jennifer, et al.
Publicado: (2020)

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer
por: Nicholson, RI, et al.
Publicado: (2000)

Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling
por: Pidsley, Ruth, et al.
Publicado: (2016)

Modelling clinical DNA fragmentation in the development of universal PCR-based assays for bisulfite-converted, formalin-fixed and cell-free DNA sample analysis
por: Johnston, Andrew D., et al.
Publicado: (2022)

Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
por: Pidsley, Ruth, et al.
Publicado: (2022)

Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing
por: Lane, Rebecca E., et al.
Publicado: (2015)

Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies
por: Constantin, Nicolas, et al.
Publicado: (2022)

PrimerROC: accurate condition-independent dimer prediction using ROC analysis
por: Johnston, Andrew D., et al.
Publicado: (2019)

Evaluation of Different Oligonucleotide Base Substitutions at CpG Binding sites in Multiplex Bisulfite-PCR sequencing
por: Lu, Jennifer, et al.
Publicado: (2017)

PrimerSuite: A High-Throughput Web-Based Primer Design Program for Multiplex Bisulfite PCR
por: Lu, Jennifer, et al.
Publicado: (2017)

Oestrogenic Endocrine Disruptors in the Placenta and the Fetus
por: Tang, Zi-Run, et al.
Publicado: (2020)

Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.
por: McClelland, R. A., et al.
Publicado: (1998)

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Meyer, Braydon, et al.
Publicado: (2021)

Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer
por: Stone, Andrew, et al.
Publicado: (2012)

Enduring epigenetic landmarks define the cancer microenvironment
por: Pidsley, Ruth, et al.
Publicado: (2018)

MethPanel: a parallel pipeline and interactive analysis tool for multiplex bisulphite PCR sequencing to assess DNA methylation biomarker panels for disease detection
por: Luu, Phuc-Loi, et al.
Publicado: (2020)

Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA
por: Skvortsova, Ksenia, et al.
Publicado: (2017)

Network mapping of primary CD34+ cells by Ampliseq based whole transcriptome targeted resequencing identifies unexplored differentiation regulatory relationships
por: Schwaber, Jessica L., et al.
Publicado: (2021)

Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors
por: Lee, Hye-Rim, et al.
Publicado: (2013)

Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
por: Borley, Annabel C, et al.
Publicado: (2008)

Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity
por: Stone, A, et al.
Publicado: (2008)

Oestrogen receptors and the response to endocrine therapy in advanced breast cancer.
por: Roberts, M. M., et al.
Publicado: (1978)

Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas
por: Lim, Annette M., et al.
Publicado: (2016)

Do classical oestrogen markers predict for clinical response to endocrine therapy?
por: Miller, William R
Publicado: (2007)

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
por: Achinger-Kawecka, Joanna, et al.
Publicado: (2020)

Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges
por: Lane, R. E., et al.
Publicado: (2018)

Estrogen receptor degradation: a CUE for endocrine resistance?
por: Musgrove, Elizabeth A
Publicado: (2011)

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
por: Anderson, E. D., et al.
Publicado: (1989)

Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability.
por: Leake, R. E., et al.
Publicado: (1981)

Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
por: Gee, Julia MW, et al.
Publicado: (2004)

Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.
por: Sharma, A. K., et al.
Publicado: (1994)

Oestrogens and oestrogen receptors in prostate cancer
por: Kowalska, Karolina, et al.
Publicado: (2016)

Loss of oestrogen receptor alpha in long-term antioestrogen-resistant cells: reversal by a c-src inhibitor
por: Bensmail, A, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_on03fi4gie5lvs7o57qapbikop